In addition, the fact that high levels of Lymphotoxin (LT)-α have been associated with autoimmune and inflammatory contexts [19], and that increased LT-α to IL-10 B-cell expression ratios have been observed in patients with multiple sclerosis [20], prompted us to also assess B-cell LT-α expression profiles. The gene discussed is LTA; the disease is multiple sclerosis.